caffeine has been researched along with Movement Disorders in 7 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Movement disorders including Parkinson's disease (PD), Huntington's disease (HD), chorea, tics, and Tourette's syndrome (TS) display sex differences in disease susceptibility, disease pathogenesis, and clinical presentation." | 2.50 | Sex differences in Parkinson's disease and other movement disorders. ( Dahodwala, N; Smith, KM, 2014) |
| "Caffeine was overall well tolerated, even in children, and 87% of patients reported a clear improvement." | 1.72 | Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study. ( Anheim, M; Barth, M; Cif, L; Damier, P; DeGusmao, C; Demonceau, N; Doulazmi, M; Doummar, D; Friedman, J; Gallea, C; Gras, D; Gurgel-Giannetti, J; Innes, EA; Méneret, A; Mohammad, SS; Necpál, J; Paramanandam, V; Pringsheim, T; Riant, F; Roze, E; Sagnes, S; Sarret, C; Seliverstov, Y; Shetty, K; Tranchant, C; Vidailhet, M, 2022) |
| "Caffeine alone did not produce any significant modification in functional impairment but the co-administration significantly increased the effect of naproxen." | 1.29 | Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesics to their efficacy in rats. ( Hoyo-Vadillo, C; López-Munoz, FJ; Pérez-Urizar, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Méneret, A | 1 |
| Mohammad, SS | 1 |
| Cif, L | 1 |
| Doummar, D | 1 |
| DeGusmao, C | 1 |
| Anheim, M | 1 |
| Barth, M | 1 |
| Damier, P | 1 |
| Demonceau, N | 1 |
| Friedman, J | 1 |
| Gallea, C | 1 |
| Gras, D | 1 |
| Gurgel-Giannetti, J | 1 |
| Innes, EA | 1 |
| Necpál, J | 1 |
| Riant, F | 1 |
| Sagnes, S | 1 |
| Sarret, C | 1 |
| Seliverstov, Y | 1 |
| Paramanandam, V | 1 |
| Shetty, K | 1 |
| Tranchant, C | 1 |
| Doulazmi, M | 1 |
| Vidailhet, M | 1 |
| Pringsheim, T | 1 |
| Roze, E | 1 |
| Smith, KM | 1 |
| Dahodwala, N | 1 |
| Kalia, LV | 1 |
| Brotchie, JM | 1 |
| Fox, SH | 1 |
| Kasim, S | 1 |
| Jinnah, HA | 1 |
| Hoyo-Vadillo, C | 1 |
| Pérez-Urizar, J | 1 |
| López-Munoz, FJ | 1 |
| Gardos, G | 1 |
| Popoli, P | 1 |
| Caporali, MG | 1 |
| Scotti de Carolis, A | 1 |
2 reviews available for caffeine and Movement Disorders
| Article | Year |
|---|---|
Sex differences in Parkinson's disease and other movement disorders.
Topics: Androgens; Animals; Caffeine; Chorea Gravidarum; Dopamine; Estrogens; Female; Humans; Huntington Dis | 2014 |
Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
Topics: Acetylcholine; Adenosine A3 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Antiparkins | 2013 |
5 other studies available for caffeine and Movement Disorders
| Article | Year |
|---|---|
Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
Topics: Adenylyl Cyclases; Caffeine; Child; Dyskinesias; Humans; Movement Disorders; Retrospective Studies | 2022 |
Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesics to their efficacy in rats.
Topics: Analgesics; Animals; Caffeine; Drug Interactions; Female; Movement Disorders; Naproxen; Pain Measure | 1995 |
Dyskinesia after discountinuation of compound analgesic containing oxycodone.
Topics: Aspirin; Caffeine; Codeine; Drug Combinations; Female; Humans; Middle Aged; Movement Disorders; Oxyc | 1977 |
Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility.
Topics: Adenosine; alpha-Methyltyrosine; Animals; Caffeine; Catecholamines; Dose-Response Relationship, Drug | 1991 |